Synthetic Vaccine Particles News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Synthetic vaccine particles. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Synthetic Vaccine Particles Today - Breaking & Trending Today

HC Wainwright Increases Selecta Biosciences (NASDAQ:SELB) Price Target to $5.00

Selecta Biosciences (NASDAQ:SELB – Get Rating) had its price target raised by equities research analysts at HC Wainwright from $4.00 to $5.00 in a research note issued to investors on Wednesday, The Fly reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s price objective would suggest a potential upside of 244.83% […] ....

Selecta Biosciences , Carsten Brunn , Needham Company , Eqis Capital Management Inc , Selecta Biosciences Inc , Canaccord Genuity Group , Pricet Rowe Associates Inc , Virtu Financial , Prudential Financial Inc , Beacon Pointe Advisors , Selecta Biosciences Company Profile , Get Rating , Capital Management , Synthetic Vaccine Particles , Selecta Biosciences Daily , Nasdaq Selb , Boost Price Target , Hc Wainwright ,

Selecta Biosciences (NASDAQ:SELB) Stock Rating Lowered by StockNews.com

Selecta Biosciences (NASDAQ:SELB – Get Rating) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday. A number of other brokerages also recently issued reports on SELB. Zacks Investment Research upgraded shares of Selecta Biosciences from a “strong sell” rating to a […] ....

Los Angeles , United States , Selecta Biosciences , Wells Fargo Company , Zacks Investment Research , Selecta Biosciences Company Profile Get Rating , Selecta Biosciences Inc , Los Angeles Capital Management , Asset Management , Invesco Ltd , Get Rating , Investment Research , Angeles Capital Management , Biosciences Company Profile , Synthetic Vaccine Particles , Nasdaq Selb , Stocknews Com ,

Brokerages Expect Selecta Biosciences, Inc. (NASDAQ:SELB) Will Announce Earnings of -$0.09 Per Share

Equities research analysts expect Selecta Biosciences, Inc. (NASDAQ:SELB – Get Rating) to announce ($0.09) earnings per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for Selecta Biosciences’ earnings. Selecta Biosciences posted earnings per share of ($0.22) in the same quarter last year, which suggests a positive year-over-year […] ....

Thomson Reuter , Carsten Brunn , Selecta Bioscience , Selecta Biosciences , Geode Capital Management , Securities Exchange Commission , Zacks Investment Research , Blackrock Inc , Marshall Wace , Selecta Biosciences Inc , Nanodimension Inc , Get Rating , Zacks Investment , Investment Research , Exchange Commission , Capital Management , State Street Corp , Street Corp , Synthetic Vaccine Particles , Nasdaq Selb ,

Selecta Biosciences (NASDAQ:SELB) Posts Earnings Results, Beats Estimates By $0.09 EPS

Selecta Biosciences (NASDAQ:SELB – Get Rating) announced its earnings results on Thursday. The company reported $0.03 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.06) by $0.09, MarketWatch Earnings reports. During the same period in the prior year, the firm earned ($0.14) earnings per share. SELB stock traded down $0.10 during mid-day […] ....

Thomson Reuter , Timothya Springer , Selecta Biosciences , Securities Exchange Commission , Squarepoint Ops , Virtu Financial , Zacks Investment Research , Selecta Biosciences Company Profile Get Rating , Selecta Biosciences Inc , Invesco Ltd , Get Rating , Marketwatch Earnings , Investment Research , Director Timothy , Exchange Commission , Biosciences Company Profile , Synthetic Vaccine Particles , Nasdaq Selb ,

Selecta Biosciences (SELB) Received its Third Buy in a Row

Selecta Biosciences (SELB) Received its Third Buy in a Row
markets.co - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from markets.co Daily Mail and Mail on Sunday newspapers.

Roberts Langer Jr , Selecta Bioscience , Omidc Farokhzad , Selecta Biosciences , William Blair , Ram Selvaraju , Selecta Biosciences Inc , Neurobo Pharmaceuticals , Analyst Ram Selvaraju , Aquestive Therapeutics , Strong Buy , Synthetic Vaccine Particles ,